WO2015081803A1 - 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 - Google Patents
一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 Download PDFInfo
- Publication number
- WO2015081803A1 WO2015081803A1 PCT/CN2014/092299 CN2014092299W WO2015081803A1 WO 2015081803 A1 WO2015081803 A1 WO 2015081803A1 CN 2014092299 W CN2014092299 W CN 2014092299W WO 2015081803 A1 WO2015081803 A1 WO 2015081803A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bclo
- fluorescent probe
- dipyrromethene
- fluorescence
- boron fluoride
- Prior art date
Links
- 239000000523 sample Substances 0.000 title abstract description 41
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 claims abstract description 19
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 62
- 150000001875 compounds Chemical class 0.000 claims description 57
- 239000007850 fluorescent dye Substances 0.000 claims description 52
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 45
- 229910015900 BF3 Inorganic materials 0.000 claims description 34
- OVTCUIZCVUGJHS-UHFFFAOYSA-N dipyrrin Chemical compound C=1C=CNC=1C=C1C=CC=N1 OVTCUIZCVUGJHS-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract description 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- -1 O2 - Chemical compound 0.000 abstract description 5
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 30
- 239000005708 Sodium hypochlorite Substances 0.000 description 27
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 27
- 238000002474 experimental method Methods 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 230000005284 excitation Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000975 dye Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000006184 cosolvent Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- CESGKXMBHGUQTB-VONOSFMSSA-N [(1S,2S,6R,10S,11R,13S,14R,15R)-1,6,14-trihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(OC(=O)CCCCCCCCCCCCC)C(C)(C)[C@H]3[C@@H]21 CESGKXMBHGUQTB-VONOSFMSSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000003642 reactive oxygen metabolite Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000010226 confocal imaging Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000007080 aromatic substitution reaction Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 0 *C1=CN=C(*)*1 Chemical compound *C1=CN=C(*)*1 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000027832 depurination Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005616 pyroelectricity Effects 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000035440 response to pH Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1022—Heterocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Definitions
- the invention relates to a fluorescent probe, a preparation method and a use thereof, and particularly relates to a boron fluoride complexed dipyrromethene fluorescent probe, a preparation method thereof and application thereof in the detection of hypochlorite.
- Fluorescent probes have been widely used as functional dyes in various fields of science and technology, especially in the fields of life sciences, clinical medical diagnosis, and immunoassay detection.
- fluorescent dyes boron fluoride complexed dipyrromethene (BDP) fluorescent dyes have high molar extinction coefficient, high fluorescence quantum yield, stable spectral properties, high photothermal, good chemical stability, small molecular weight and cytotoxicity.
- BDP boron fluoride complexed dipyrromethene
- hypochlorous acid As an important active oxygen in living organisms, hypochlorous acid (HClO) is physiologically mainly produced by the reaction of chloride ions and hydrogen peroxide under the action of myeloperoxidase. In the cellular environment, due to the strong oxidizing properties of hypochlorous acid/hypochlorite, it can kill foreign bacteria, prevent invasion, and regulate the cell life cycle. As we age, the concentration of hypochlorous acid in the human body will gradually increase. However, excessive hypochlorous acid/hypochlorite causes a series of diseases such as osteoarthritis, cardiovascular disease, etc. Therefore, the development of an effective method for monitoring hypochlorous acid has attracted more and more researchers' attention.
- probes that can be used to detect hypochlorous acid/hypochlorite in aqueous solutions or organisms. These probes are mainly based on the strong oxidizing properties of hypochlorous acid, such as: oxidation mechanism of dibenzoyl hydrazide; oxidation of hydroxamic acid; mechanism of depurination; oxidation mechanism of p-methoxyphenol; mechanism of sulfur atom oxidation.
- these probes generally have shortcomings such as long response time, low sensitivity, poor selectivity, and vulnerability to pH interference.
- Pyrrole is an important raw material for the synthesis of BDP, and we have found that it can be selectively oxidized by hypochlorous acid to be insensitive to other reactive oxygen species (such as H 2 O 2 , ⁇ OH, etc.). Moreover, since pyrrole is aromatic and the unshared electron pair on the nitrogen participates in the formation of a cyclic large ⁇ bond, its ability to bind to protons is impaired, so that pH interference can be well avoided. In addition, the pyroelectricity of pyrrole makes it effective to produce photoinduced electron transfer (PET) effects on some fluorophores, thereby reducing background fluorescence and improving probe sensitivity.
- PET photoinduced electron transfer
- the present invention provides a class of boron fluoride complexed dipyrromethene fluorescent probes, , 4-dimethylpyrrole is a recognition group, and boron fluoride complexes dipyrromethene dye as a fluorophore, which improves probe selectivity (not interfered by other reactive oxygen species and pH) and sensitivity, accelerates response time, and has Good biological applications.
- a type of boron fluoride complexed dipyrromethene fluorescent probe having the following structural formula I:
- R 1 , R 2 and R 3 are each independently selected from H, C 1-8 alkyl, substituted or unsubstituted phenyl;
- the substituted phenyl group is a phenyl group substituted by any one or more of the following groups: CN, COOH, NH 2 , NO 2 , OH, SH, C 1-6 alkoxy, C 1-6 alkyl Amino, C 1-6 amide, halogen or C 1-6 haloalkyl.
- the method for preparing a boron fluoride complexed dipyrromethene fluorescent probe comprises the steps of: reacting a compound having the structural formula II with acryloyl chloride in a molar ratio of from 1 to 5:1, and then in the presence of a base And complexing with boron trifluoride to obtain the boron fluoride complexed dipyrromethene fluorescent probe;
- the boron fluoride complexed dipyrromethene fluorescent probe of the present invention has the following remarkable features:
- Figure 1 is the fluorescence intensity of the fluorescent probe compound BClO for different concentrations of hypochlorite in the BClO performance measurement experiment 1. Degree response graph. The concentration of the probe compound BClO was 1 ⁇ M, and the concentrations of sodium hypochlorite were 0, 1, 2, 3, 4, 5, 6, and 7 ⁇ M, respectively.
- Figure 1a is a fluorescence titration spectrum of sodium hypochlorite by BClO with an excitation wavelength of 480 nm
- Figure 1b is a titration curve of BClO to sodium hypochlorite with an excitation wavelength of 480 nm.
- Figure 2 is a sample of the fluorescent probe compound BClO in the BClO performance measurement experiment 2 for different concentrations of hypochlorite absorption titration test.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M, and the concentrations of sodium hypochlorite were 0, 1, 2, 3, 4, 5, 6, and 7 ⁇ M, respectively.
- Fig. 3 is a fluorescence selective histogram of the fluorescent probe compound BClO for different reactive oxygen species in Experiment 3 of BClO performance measurement.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M, the concentration of sodium hypochlorite was 5 ⁇ M, and the concentration of other active oxygen was 10 ⁇ M.
- Figure 4 is a graph showing the fluorescence intensity response of the fluorescent probe compound BClO to low concentration hypochlorite in the BClO performance measurement experiment 4.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M, and the concentrations of sodium hypochlorite were 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 nM, respectively.
- Fig. 5 is a graph showing the response time of the fluorescent probe compound BClO to the detection of sodium hypochlorite in the BClO performance measurement experiment 5.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M, and the concentration of sodium hypochlorite added was 5 ⁇ M.
- the abscissa is time (s) and the ordinate is fluorescence intensity.
- Fig. 6 is a graph showing the fluorescence intensity response of the probe compound BClO to hypochlorite at different pH values in the experiment 6 of the BClO performance measurement.
- the abscissa is pH and the ordinate is fluorescence intensity.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M, and the concentration of sodium hypochlorite added was 5 ⁇ M.
- the pH was adjusted with NaOH (1 M) and HCl (1 M).
- Figure 7 is a fluorescent image of the probe compound BClO in human breast cancer (MCF-7) cells in BClO performance assay experiment 7.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M.
- a, b, and c respectively indicate fluorescence photographs in the 490 nm-550 nm band after addition of 0, 3, and 5 ⁇ M sodium hypochlorite in BClO-stained cells.
- the excitation wavelength was 488 nm.
- Figure 8 is a fluorescent image of the probe compound BClO in mouse macrophage (Raw 264.7) cells in the BClO performance assay experiment 8.
- the concentration of the fluorescent probe compound BClO was 1 ⁇ M.
- a indicates fluorescence staining of cells after addition of BClO;
- b indicates that Raw 264.7 cells were cultured with 1 ⁇ g/mL of LPS (lipopolysaccharide) for 12 hours, and then incubated with 1 ⁇ g/mL of PMA (phorbol myristate) Fluorescence photographs of cells stained with BClO were added 1 hour later. Fluorescence in the 490 nm-550 nm band was acquired with an excitation wavelength of 488 nm.
- the present invention provides a class of boron fluoride complexed dipyrromethene fluorescent probes having the structural formula I.
- R 1 , R 2 and R 3 are each independently selected from H, C 1-8 alkyl, substituted or unsubstituted phenyl;
- the substituted phenyl group is a phenyl group substituted by any one or more of the following groups: CN, COOH, NH 2 , NO 2 , OH, SH, C 1-6 alkoxy, C 1-6 alkyl Amino, C 1-6 amide, halogen or C 1-6 haloalkyl.
- R 1 and R 3 are each independently selected from H or methyl, more preferably methyl;
- R 2 is preferably hydrogen or ethyl, more preferably hydrogen.
- the boron fluoride complexed dipyrromethene fluorescent probe of the present invention is BClO, and the structural formula is as follows:
- the present invention further provides a method for preparing the boron fluoride complexed dipyrromethene fluorescent probe, comprising the steps of: reacting a compound having the structural formula II with acryloyl chloride in a molar ratio of from 1 to 5:1, and then in a base.
- the boron fluoride complexed dipyrromethene fluorescent probe is obtained by complexing with boron trifluoride in the presence of the boron fluoride;
- the compound having the structural formula II and the acryloyl chloride are prepared as the intermediate compound III: the molar ratio of the intermediate compound II to the acryloyl chloride can be from 0.1 to 1000:1, preferably from 0.5 to 100:1, more preferably from 0.5 to 10: 1, further preferably 1-5:1, most preferably 3:1, and a condensation reaction occurs to form a compound of the formula III.
- the above reaction can be carried out in an aqueous organic solvent or an anhydrous organic solvent. It is preferably an anhydrous organic solvent.
- the molar concentration of the pyrrole starting material in the solvent is from 0.012 to 0.4 mol/L.
- Organic solvents include, but are not limited to, dichloromethane, tetrahydrofuran or acetonitrile.
- the pyrrole starting material and the acryloyl chloride are condensed twice to form the active intermediate III. Since the product is unstable, the next reaction can be directly carried out without separation, and the end point of the reaction is judged by thin layer chromatography (TLC).
- the reaction temperature should be controlled between 15 ° C and 120 ° C. Since the pyrrole molecule is liable to self-polymerize at a high temperature, a viscous brown substance is formed, thereby affecting the main reaction and greatly reducing the yield. When the reaction temperature is too low, it takes a long time to make the reaction sufficient. Therefore, the reaction temperature is preferably from 30 ° C to 100 ° C, further preferably from 30 ° C to 80 ° C, and most preferably from 40 ° C to 60 ° C.
- the intermediate III obtained in the step 1 is reacted with a boron trifluoride compound, an organic base is added, and hydrogen fluoride is removed to form a product of the formula I.
- the boron trifluoride compound to be added may be a gaseous boron trifluoride, a boron trifluoride diethyl ether complex or any other compound capable of releasing boron trifluoride at a normal temperature solution.
- the above reaction temperature is -10 ° C - 100 ° C, preferably 0 ° C - 10 ° C; the addition of boron trifluoride compounds (such as gaseous boron trifluoride or boron trifluoride complex) requires the addition of an organic base to promote the reaction
- the organic base is preferably triethylamine.
- the method for purifying the boron fluoride complexed dipyrromethene fluorescent dye of the present invention is carried out by a conventional method, and is not particularly limited. Usually, after the reaction is completed, the solvent is distilled off. Preferably, the product is purified by column chromatography using petroleum ether/ethyl acetate as an eluent.
- the resulting fluorescent dye can be recovered by separation and purification techniques well known in the art to achieve the desired purity.
- aromatic substitution reaction examples include introduction of a nitro group with concentrated nitric acid, introduction of an acyl group under Friedel Crafts conditions using, for example, an acid halide and a Lewis acid (such as aluminum trichloride), and an alkyl halide and a Lewis acid (such as aluminum trichloride).
- the alkyl group is introduced under the conditions of Friedel Crafts, and a halogen group is introduced.
- modification examples include reduction of a nitro group to an amino group by, for example, catalytic hydrogenation with a nickel catalyst or heat treatment with iron in the presence of hydrochloric acid; oxidation of an alkylthio group to an alkylsulfinyl group or an alkylsulfonyl group.
- alkyl as used herein includes both straight chain alkyl and branched alkyl groups.
- a single alkyl group such as "propyl”
- a single branched-chain alkyl group such as "isopropyl”
- C 1-4 alkyl includes methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl and the like. Similar rules apply to the other groups used in this specification.
- the use of the boron fluoride complexed dipyrromethene fluorescent probe of the invention for detecting hypochlorite is particularly suitable for detecting hypochlorite in living cells.
- 2,4-Dimethylpyrrole (2.8 g, 30 mmol) was added to a 500 mL single-necked flask containing 250 mL of dichloromethane, and then (0.9 g, 10 mmol) of acryloyl chloride was added, protected from light and nitrogen, and stirred at 50 ° C overnight. Under ice-cooling conditions, 10 mL of triethylamine and 10 mL of boron trifluoride diethyl ether were added dropwise, and stirring was continued for 1 hour. The solvent was evaporated under reduced pressure and the crystals were separated to afford white crystals (EtOAc).
- the fluorescent probe compound BClO has high selectivity to sodium hypochlorite, and the addition of 5 ⁇ M sodium hypochlorite makes the fluorescence intensity of BClO significantly enhanced (100 times), while the addition of other active oxygen has no significant change.
- the response to the nanomolar concentration of hypochlorite was evaluated using the compound BClO synthesized above.
- Figure 5 is a time function of the detection of hypochlorite by the probe compound BClO.
- concentration of the probe compound BClO was 1 ⁇ M
- the excitation wavelength was 480 nm
- the fluorescence intensity of BClO at 505 nm with time was recorded. It can be seen from Figure 5 that BClO responds very rapidly to hypochlorite and reaches equilibrium within one second.
- the abscissa is time (seconds) and the ordinate is fluorescence intensity.
- the response to pH was evaluated using the compound BClO synthesized above.
- the pH was adjusted to about 4.0 in the PBS buffer (containing 10% by volume of ethanol as a dye cosolvent), and the excitation wavelength was 480 nm.
- the alkali solution was added to slowly increase the pH to about 9.0, and the corresponding change in fluorescence intensity was recorded.
- the probe compound BClO can be used for the detection of hypochlorite in this pH range.
- the abscissa is pH and the ordinate is fluorescence intensity.
- the pH was adjusted with NaOH (1 M) and HCl (1 M) in the experiment.
- MCF-7 cells were cultured in DEME (invitrogen) with 10% FCS (invitrogen).
- DEME invitrogen
- FCS invitrogen
- the cells were seeded in dedicated cell confocal culture dishes.
- 1 ⁇ M of the probe compound BClO was added thereto, kept at 37 ° C and 5% CO 2 for 20 minutes, and then washed 3 times with a phosphate buffer solution for confocal imaging. Under the same conditions, 3 ⁇ M and 5 ⁇ M sodium hypochlorite were added separately, and confocal imaging was performed immediately.
- the culture density of the cells was 2 ⁇ 10 5 cells/mL.
- the instrument used for imaging was an Olympus FV1000-IX81 inverted microscope with a 100x oil mirror. The excitation light was excited at 488 nm and the 490-550 nm band was collected.
- Figures 7a-c are photographs of live cell staining before and after the addition of BClO to sodium hypochlorite.
- the probe compound BClO emits weak green fluorescence in the cells, which is due to the fact that MCF-7 cells contain a certain amount of reactive oxygen species, and the fluorescence intensity is fast after the addition of sodium hypochlorite.
- the probe compound BClO is suitable for the detection of hypochlorous acid in living cells.
- Raw264.7 cells were cultured in DEME (invitrogen) with 10% FCS (invitrogen). One day before the confocal fluorescence imaging experiment, the cells were seeded in dedicated cell confocal culture dishes. On the next day, 1 ⁇ M of the probe compound BClO was added thereto, kept at 37 ° C and 5% CO 2 for 20 minutes, and then washed 3 times with a phosphate buffer solution for confocal imaging. Under the same conditions, Raw264.7 cells were incubated with 1 ⁇ g/mL of LPS (lipopolysaccharide) for 12 hours, and then incubated with 1 ⁇ g/mL of PMA (phorbol myristate) for 1 hour, and then 1 ⁇ M was added thereto. The probe compound BClO was incubated at 37 ° C and 5% CO 2 for 20 minutes, and then washed 3 times with a phosphate buffer solution for confocal imaging.
- LPS lipopolysaccharide
- PMA phor
- the culture density of the cells was 2 ⁇ 10 5 cells/mL.
- the instrument used for imaging was an Olympus FV1000-IX81 inverted microscope with a 100x oil mirror. The excitation light was excited at 488 nm and the 490-550 nm band was collected.
- Figures 8a-b are photographs of BClO staining of Raw264.7 cells before and after stimulation with LPS and PMA, respectively.
- the probe compound BClO emits very weak green fluorescence in macrophages due to the low content of reactive oxygen species in Raw264.7 cells, and the fluorescence intensity after stimulation with LPS and PMA.
- the probe compound BClO is suitable for the detection of endogenous hypochlorous acid in living cells.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
Claims (9)
- 根据权利要求1所述的氟化硼络合二吡咯甲川荧光探针,其特征在于所述R1和R3各自独立地选自H或甲基。
- 根据权利要求2所述的氟化硼络合二吡咯甲川荧光探针,其特征在于所述R1和R3均为甲基。
- 根据权利要求1~3中任一权利要求所述的氟化硼络合二吡咯甲川荧光探针,其特征在于所述R2选自氢或乙基。
- 根据权利要求4所述的氟化硼络合二吡咯甲川荧光探针,其特征在于所述R2为氢。
- 根据权利要求6所述的制备方法,其特征在于具有结构通式II的化合物与丙烯酰氯的反应摩尔比为3:1。
- 权利要求1-5中任意一项权利要求所述的氟化硼络合二吡咯甲川荧光探针在检测次氯酸根中的应用。
- 根据权利要求8所述的氟化硼络合二吡咯甲川荧光探针在检测次氯酸根中的应用,其特征在于所述氟化硼络合二吡咯甲川荧光探针用于活细胞中次氯酸根的检测。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14867001.1A EP3078666B1 (en) | 2013-12-02 | 2014-11-26 | Boron-dipyrromethene fluorescence probes and manufacturing method and use thereof |
US15/039,674 US9862731B2 (en) | 2013-12-02 | 2014-11-26 | Difluoroboron dipyrromethene fluorescent probe, production method and application thereof |
JP2016535729A JP6275256B2 (ja) | 2013-12-02 | 2014-11-26 | ボロンジピロメテン蛍光プローブ、その製造方法及び応用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310643027.8A CN103666456B (zh) | 2013-12-02 | 2013-12-02 | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 |
CN201310643027.8 | 2013-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015081803A1 true WO2015081803A1 (zh) | 2015-06-11 |
Family
ID=50305247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/092299 WO2015081803A1 (zh) | 2013-12-02 | 2014-11-26 | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9862731B2 (zh) |
EP (1) | EP3078666B1 (zh) |
JP (1) | JP6275256B2 (zh) |
CN (1) | CN103666456B (zh) |
WO (1) | WO2015081803A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103666456B (zh) * | 2013-12-02 | 2015-02-04 | 大连理工大学 | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 |
CN106349261B (zh) * | 2015-07-16 | 2019-03-26 | 中国科学院上海药物研究所 | 荧光开关型bodipy类化合物及其制备方法和应用 |
CN106220664B (zh) * | 2016-08-10 | 2018-06-22 | 浙江大学 | 一种检测自噬流的荧光探针及其制备和应用 |
CN107253965B (zh) * | 2017-06-29 | 2019-07-05 | 大连大学 | 一类基于氟硼吡咯和香豆素的fret分子及其合成方法 |
CN109574880B (zh) * | 2017-09-29 | 2022-06-17 | 纳莹(上海)生物科技有限公司 | 一种荧光探针及其制备方法和用途 |
CN109535190B (zh) * | 2018-10-26 | 2021-01-01 | 安徽师范大学 | meso-吡咯酮BODIPY染料粘度探针及其制备方法和应用 |
CN109608396B (zh) * | 2018-12-29 | 2021-11-26 | 大连理工大学 | 用于MicroRNA检测的复合探针组合物及其用途 |
CN112574239B (zh) * | 2019-09-27 | 2022-03-25 | 中国科学院上海药物研究所 | 3-噻唑烯基氟化硼络合二吡咯甲川类化合物及其制备方法和用途 |
CN111187288B (zh) * | 2020-01-14 | 2023-04-28 | 安徽师范大学 | 3,8-二吡咯-bodipy荧光染料的制备方法和次氯酸根的定性检测方法 |
CN113683632B (zh) * | 2021-07-22 | 2023-11-28 | 广东省科学院测试分析研究所(中国广州分析测试中心) | 一种近红外钯离子荧光探针化合物及其合成方法 |
CN115028662B (zh) * | 2022-07-19 | 2024-06-28 | 浙江理工大学 | 一种检测次氯酸的荧光探针及其制备方法与使用方法 |
CN115343267B (zh) * | 2022-08-30 | 2023-07-04 | 广州大学 | 一种次氯酸根离子的荧光检测方法及其应用 |
CN115677744A (zh) * | 2022-10-31 | 2023-02-03 | 太原工业学院 | 一种用于检测Ag+的荧光探针及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000001509A (ja) * | 1998-06-17 | 2000-01-07 | Kansai Paint Co Ltd | 可視光硬化性樹脂組成物及びその用途 |
CN1715919A (zh) * | 2005-07-12 | 2006-01-04 | 大连理工大学 | 细胞锌离子检测用的氟硼染料荧光探针 |
CN1944540A (zh) * | 2006-09-15 | 2007-04-11 | 大连理工大学 | 生物分析用近红外氟化硼络合二吡咯甲川类荧光染料 |
CN101851500A (zh) * | 2010-05-05 | 2010-10-06 | 大连理工大学 | 汞离子检测用氟硼染料荧光探针 |
CN101883775A (zh) * | 2007-03-12 | 2010-11-10 | 弗西蒂技术有限公司 | 用于检测次氯酸的试剂 |
CN102061103A (zh) * | 2009-11-11 | 2011-05-18 | 大连理工大学 | 一类氟化硼络合二吡咯甲川染料、制备方法及其应用 |
CN102702768A (zh) * | 2012-06-04 | 2012-10-03 | 天津理工大学 | 一种新型红光bodipy荧光染料及其制备方法和应用 |
KR20120110620A (ko) * | 2011-03-30 | 2012-10-10 | 단국대학교 산학협력단 | 고반응성 산소종 검출용 형광 분자 영상 프로브 및 이의 제조방법 |
CN102816826A (zh) * | 2012-08-08 | 2012-12-12 | 南京大学 | 氟化硼络合二吡咯甲川荧光染料-杯[4]芳烃复合物作为探针在细胞pH检测中的应用 |
CN102993763A (zh) * | 2012-12-09 | 2013-03-27 | 大连理工大学 | 一类单电荷氟化硼络合二吡咯甲川荧光染料及其应用 |
CN103666456A (zh) * | 2013-12-02 | 2014-03-26 | 大连理工大学 | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000039716A (ja) | 1998-07-22 | 2000-02-08 | Kansai Paint Co Ltd | ポジ型可視光感光性樹脂組成物及びその用途 |
EP1402263B1 (en) * | 2001-07-02 | 2009-10-28 | Arctic Diagnostics OY | Two-photon absorbing dipyrrometheneboron difluoride dyes and their applications |
KR101035236B1 (ko) * | 2008-09-04 | 2011-05-18 | 한국원자력연구원 | Bodipy가 결합된 크라운 에테르 유도체, 이를 제조하는 방법 및 이를 이용하여 금속 이온을 선택적으로 검출하는 방법 |
-
2013
- 2013-12-02 CN CN201310643027.8A patent/CN103666456B/zh active Active
-
2014
- 2014-11-26 WO PCT/CN2014/092299 patent/WO2015081803A1/zh active Application Filing
- 2014-11-26 JP JP2016535729A patent/JP6275256B2/ja active Active
- 2014-11-26 US US15/039,674 patent/US9862731B2/en active Active
- 2014-11-26 EP EP14867001.1A patent/EP3078666B1/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000001509A (ja) * | 1998-06-17 | 2000-01-07 | Kansai Paint Co Ltd | 可視光硬化性樹脂組成物及びその用途 |
CN1715919A (zh) * | 2005-07-12 | 2006-01-04 | 大连理工大学 | 细胞锌离子检测用的氟硼染料荧光探针 |
CN1944540A (zh) * | 2006-09-15 | 2007-04-11 | 大连理工大学 | 生物分析用近红外氟化硼络合二吡咯甲川类荧光染料 |
CN101883775A (zh) * | 2007-03-12 | 2010-11-10 | 弗西蒂技术有限公司 | 用于检测次氯酸的试剂 |
CN102061103A (zh) * | 2009-11-11 | 2011-05-18 | 大连理工大学 | 一类氟化硼络合二吡咯甲川染料、制备方法及其应用 |
CN101851500A (zh) * | 2010-05-05 | 2010-10-06 | 大连理工大学 | 汞离子检测用氟硼染料荧光探针 |
KR20120110620A (ko) * | 2011-03-30 | 2012-10-10 | 단국대학교 산학협력단 | 고반응성 산소종 검출용 형광 분자 영상 프로브 및 이의 제조방법 |
CN102702768A (zh) * | 2012-06-04 | 2012-10-03 | 天津理工大学 | 一种新型红光bodipy荧光染料及其制备方法和应用 |
CN102816826A (zh) * | 2012-08-08 | 2012-12-12 | 南京大学 | 氟化硼络合二吡咯甲川荧光染料-杯[4]芳烃复合物作为探针在细胞pH检测中的应用 |
CN102993763A (zh) * | 2012-12-09 | 2013-03-27 | 大连理工大学 | 一类单电荷氟化硼络合二吡咯甲川荧光染料及其应用 |
CN103666456A (zh) * | 2013-12-02 | 2014-03-26 | 大连理工大学 | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 |
Non-Patent Citations (3)
Title |
---|
CHENG, GUANGHUI ET AL.: "A highly specific BODIPY-based probe localized in mitochondria for HC10 imaging", ANALYST,., vol. 138, no. 20, 25 July 2013 (2013-07-25), pages 6091 - 6096, XP055287618 * |
See also references of EP3078666A4 * |
ZHU, HAO ET AL.: "Enhanced PET''-Based Fluorescent Probe with Ultrasensitivity for Imaging Basal and Elesclomol-Induced HC10 in Cancer Cells", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 136, no. 37, 29 August 2014 (2014-08-29), pages 12820 - 12823, XP055287620 * |
Also Published As
Publication number | Publication date |
---|---|
EP3078666B1 (en) | 2018-01-31 |
US20170029444A1 (en) | 2017-02-02 |
EP3078666A4 (en) | 2016-12-21 |
CN103666456B (zh) | 2015-02-04 |
CN103666456A (zh) | 2014-03-26 |
EP3078666A1 (en) | 2016-10-12 |
US9862731B2 (en) | 2018-01-09 |
JP2017504574A (ja) | 2017-02-09 |
JP6275256B2 (ja) | 2018-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015081803A1 (zh) | 一类氟化硼络合二吡咯甲川荧光探针,其制备方法及应用 | |
Zhao et al. | Transforming the recognition site of 4-hydroxyaniline into 4-methoxyaniline grafted onto a BODIPY core switches the selective detection of peroxynitrite to hypochlorous acid | |
CN111423423B (zh) | 一种比率型荧光探针在检测过氧亚硝基阴离子中的应用 | |
CN105670609B (zh) | 一种检测汞离子的新型罗丹明荧光探针及其制备方法 | |
CN109336835B (zh) | 用于检测髓过氧化物酶活性荧光探针及其制备方法和应用 | |
JP2006219453A (ja) | キノリン環を母核とする金属識別型二波長性蛍光分子 | |
CN109266331A (zh) | 一种基于半花菁结构测次氯酸根离子的近红外荧光探针、其制备方法及应用 | |
CN1715919A (zh) | 细胞锌离子检测用的氟硼染料荧光探针 | |
CN110878085B (zh) | 一种快速高选择性次溴酸荧光探针、制备方法与应用 | |
JP5800816B2 (ja) | 金属錯体、蛍光プローブ | |
CN114230494A (zh) | 大斯托克斯位移近红外荧光探针的合成及其在检测硫化氢中的应用 | |
CN109400563B (zh) | 一种次氯酸荧光探针及其制备方法和应用 | |
CN109021000B (zh) | 一种检测过氧化氢的荧光探针、合成方法和应用 | |
CN108752373B (zh) | 一种基于苯硼酯识别过氧化氢的荧光探针 | |
CN108383774B (zh) | 一种基于端基炔酮的半胱氨酸荧光探针及其制备和应用 | |
CN111518066B (zh) | 用于识别次氯酸根和亚硫酸氢根的双功能荧光探针及其制备方法和应用 | |
CN109912581B (zh) | 基于香豆素与苯乙烯吡啶鎓的次氯酸荧光探针及其应用 | |
Ye et al. | Design and synthesis of a new terbium complex-based luminescent probe for time-resolved luminescence sensing of zinc ions | |
CN115232152B (zh) | 检测次氯酸的荧光探针及其制备方法和应用 | |
CN107011891B (zh) | 一种Cu+荧光探针及其制备方法和应用 | |
WO2009139452A1 (ja) | 活性酸素測定用試薬 | |
CN112552901B (zh) | 一种比率型锌离子荧光探针及其制备与应用 | |
CN113025313A (zh) | 吗啉-吡啶-部花菁衍生物作为硫化氢荧光探针的应用 | |
CN111635386B (zh) | 一种单波长激发区分检测gsh和多硫化氢的荧光探针 | |
CN113387865B (zh) | 一种用于检测丙酮醛的荧光探针及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14867001 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15039674 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2016535729 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2014867001 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014867001 Country of ref document: EP |